U.S. Software Stock News

What triggered fresh interest in Lockheed Martin stock Lockheed Martin (LMT) is back in focus after historic Q2 2026 results, large long term missile contracts, and a successful AI driven fighter jet test that together sharpen visibility on its defense business. See our latest analysis for Lockheed Martin. Against this backdrop of contracts and technology milestones, Lockheed Martin’s share price has moved up to $587.95, with an 18.28% year to date share price return and a 41.65% total...

Cabot (CBT) has drawn investor attention after third quarter earnings on 3 August 2026 showed sharply lower net income and earnings per share, along with previously announced leadership changes at the top of the company. See our latest analysis for Cabot. Cabot's recent earnings miss and upcoming CEO transition sit against a share price that has climbed 30.68% year to date, with a 5 year total shareholder return of 77.28%. This suggests longer term momentum has been stronger than the shorter...

In late July 2026, Ventas, Inc. reported Q2 results showing revenue of US$1.73 billion and net income of US$70.57 million, while slightly lower basic and diluted EPS from continuing operations came in at US$0.14. At the same time, Ventas modestly raised its full-year 2026 attributable net income per share guidance range and midpoint, signaling increased confidence tied to strong senior housing operating performance and higher planned investment in that segment. Next, we’ll examine how this...

Capri Holdings Limited recently reported past first-quarter 2027 results, with sales easing to US$769 million while net income rose to US$69 million, and issued new second-quarter and full-year guidance outlining revenue pressures from Michael Kors inventory delays, softer EMEA demand and foreign exchange headwinds. Alongside this, Capri filed a US$41.30 million shelf registration for 2,500,000 common shares tied to an employee share offering, adding a capital structure element to investors’...

Cboe Global Markets recently reported record second-quarter 2026 results, with revenue rising to US$1.44 billion and net income to US$353.1 million, while also expanding Cboe Clear Europe’s Securities Financing Transactions clearing service to include fixed income lending across major EU, UK, Swiss and U.S. bond markets. This combination of stronger earnings and the move to centrally clear bond lending underscores Cboe’s push to deepen its role in global market infrastructure. We’ll now...

In the second quarter of 2026, BioLife Solutions, Inc. reported sales of US$28.47 million, up from US$23.44 million a year earlier, and moved from a net loss of US$15.84 million to net income of US$45.1 million, with basic earnings per share from continuing operations rising from a loss of US$0.32 to earnings of US$0.92. For the first half of 2026, the company’s sales increased to US$55.97 million from US$45.49 million, while net income shifted from a loss of US$16.29 million to a profit of...

In late July 2026, Guardant Health reported second-quarter 2026 results showing sales of US$334.98 million and a net loss of US$120.14 million, alongside higher full-year revenue guidance of US$1.34–1.36 billion. The company also filed an omnibus shelf registration covering multiple securities and highlighted surging Shield screening volumes supported by new UnitedHealth coverage and recent FDA approvals. Next, we’ll examine how Guardant Health’s increased 2026 revenue guidance, underpinned...

American Bitcoin Corp. ( NASDAQ:ABTC ) shareholders (or potential shareholders) will be happy to see that the...

The market seemed underwhelmed by the solid earnings posted by Costamare Bulkers Holdings Limited ( NYSE:CMDB...

Flowco Holdings Inc. ( NYSE:FLOC ) is about to trade ex-dividend in the next 3 days. The ex-dividend date is one...

Investors signalled that they were pleased with Quad/Graphics, Inc.'s ( NYSE:QUAD ) most recent earnings report...

Concentra Group Holdings Parent, Inc. ( NYSE:CON ) just released its latest second-quarter results and things are...

Loar Holdings Inc. ( NYSE:LOAR ) just released its second-quarter report and things are looking bullish. It was overall...

In recent weeks, Camden Property Trust completed the US$1.63 billion sale of its California portfolio, filed an US$802.87 million shelf registration for 7,250,000 common shares tied to an ESOP, updated 2026 earnings guidance, and finished a US$302.20 million share repurchase program covering 4,062,166 shares. These moves mark a significant repositioning of the portfolio toward newer Sunbelt assets while simultaneously shifting capital between buybacks and employee ownership, all against a...

How Owens Corning’s Latest Earnings Shape the Story for Investors Owens Corning (OC) has attracted fresh attention after its second quarter 2026 earnings update, which paired broadly steady sales with softer profits, ongoing buybacks, and clearer guidance on upcoming segment trends and costs. See our latest analysis for Owens Corning. The earnings release and the appointment of a new CFO have come alongside brisk share price momentum for Owens Corning, with a 31.1% 90-day share price return...

In August 2026, Geron Corporation reported second-quarter 2026 results showing revenue of US$57.48 million versus US$49.04 million a year earlier, alongside a six-month net loss of US$20.32 million, and issued 2026 guidance projecting RYTELO net product revenue between US$220 million and US$240 million. The company also filed a US$6.03 million shelf registration for 4,500,000 common shares tied to an ESOP, highlighting ongoing use of equity-based compensation. We’ll now examine how Geron’s...

Last week, you might have seen that Magnera Corporation ( NYSE:MAGN ) released its quarterly result to the market. The...

Pacira BioSciences recently reported that its investigational gene therapy PCRX-201 for knee osteoarthritis showed positive two-year Phase 1 results, with a single intra-articular dose appearing well tolerated and associated with improvements in pain, stiffness, and function, and incorporated glucocorticoid pretreatment into its ongoing Phase 2 ASCEND study following favorable safety findings. By pairing encouraging long-term clinical data with a successful transition to scalable U.S.-based...

Dividend affirmation puts National Bank Holdings in focus National Bank Holdings (NBHC) has drawn fresh attention after its board declared a quarterly cash dividend of $0.32 per share, payable on September 15, 2026 to shareholders of record on August 28. See our latest analysis for National Bank Holdings. Alongside the confirmed dividend, National Bank Holdings shares trade at $42.62, with the 1 month share price return down 3.86% while the year to date share price return is up 12.45% and the...

Why Primoris Services Stock Is In Focus After Its Latest Update Primoris Services (PRIM) is back on investor radars after reporting a quarterly net loss alongside a record US$13.9b backlog, while keeping full year earnings guidance intact but trimming free cash flow expectations. See our latest analysis for Primoris Services. The latest results and guidance have come after a sharp reset in sentiment toward Primoris Services, with the 90 day share price return down 27.07% and the year to date...

Covista Inc. reported past fourth-quarter 2026 results showing sales of US$501.38 million and net income of US$71.72 million, with full-year sales of US$1.95 billion and net income of US$251.57 million, alongside higher basic and diluted earnings per share versus the prior year. The company also issued fiscal 2027 revenue guidance of US$2.05–2.09 billion, implying mid-single-digit growth and signaling management’s confidence in demand for its healthcare-focused education programs. We’ll now...

Why Proto Labs Stock Is Back In Focus After Its Latest Earnings Proto Labs (PRLB) is drawing renewed investor attention after its second quarter 2026 earnings, full year outlook update, and an employee stock offering were all announced on 31 July 2026. See our latest analysis for Proto Labs. The strong second quarter update and raised 2026 revenue growth outlook have arrived alongside a sharp shift in sentiment. Proto Labs has posted a 19.5% 1 month share price return and a 92.28% 1 year...

Granite Ridge Resources, Inc. ( NYSE:GRNT ) investors will be delighted, with the company turning in some strong...

Amylyx Pharmaceuticals reported Q2 2026 results in August, with a net loss of US$43.42 million compared with US$41.44 million a year earlier, and a six‑month net loss of US$84.71 million versus US$77.35 million, even as basic loss per share from continuing operations narrowed slightly year over year. The combination of a higher absolute net loss and modest per‑share loss improvement highlights the growing cost base behind Amylyx’s development pipeline at a time when it still generates no...